4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:动物毒液多肽毒素
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > acid_base_buffer_solution > α3β2、α7和α4β2次氯酸钠的Smartox/阻滞剂
商品详细α3β2、α7和α4β2次氯酸钠的Smartox/阻滞剂
α3β2、α7和α4β2次氯酸钠的Smartox/阻滞剂
α3β2、α7和α4β2次氯酸钠的Smartox/阻滞剂
商品编号: CON019-00500
品牌: smartox-biotech
市场价: ¥6552.00
美元价: 5040.00
产地: 美国(厂家直采)
公司:
产品分类: 酸碱缓冲液
公司分类: acid_base_buffer_solution
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

 α-conotoxinGID isaconopeptideoriginallyisolatedfromthevenomofthe Conusgeographus.Itiscomposedof19aminoacidsandisfoldedbytwodisulphidebondsconnectingCys1-Cys3 andCys2-Cys4.Basedonthenumberofaminoacidsbetweenthesecondandthethirdcysteineresidues(loopI)andthethirdandfourthcysteineresidues(loopII), α-conotoxinGID belongstotheα4/7-conotoxinfamily. α-conotoxinGID blocksselectively neuronalnicotinicacetylcholinereceptorswithIC50 valuesof3nM (α3β2nicotinicreceptors),5nM (α7) and150nM (α4β2)α-conotoxinGID isatleast1000-foldlesspotentontotheα1β1γδ,α3β4,andα4β4nicotinicreceptors. α-conotoxinGID isauniqueα4/7-conotoxinbecauseofitsABIlitytoblockbothα7andα3β2isoforms,contrarytoconotoxinPnIAorPnIBthataremoreselective.

Description:

Productcode:CON019.Category:NicotinicAcetylcholineReceptor.Tags:bungarotoxin,nachr,nicotinic.

AAsequence: Ile-Arg-Asp-Gla-Cys5-Cys6-Ser-Asn-Pro-Ala-Cys11-Arg-Val-Asn-Asn-Hyp-His-Val-Cys19-OH 
Disulfidebonds:Cys5-Cys11 andCys6-Cys19
Length(aa): 19
Formula:C84H135N31O30S4
MolecularWeight:2185.45g/mol
Modifications:Gla4 aminoacid(gamma-carboxyglutamicacid)andHyp16 aminoacid(Hydroxyproline)
Appearance:Whitelyophilizedsolid
Solubility:waterandsalinebuffer
CASnumber:
Source:Synthetic
Purityrate:>95%

Reference:

Designandsynthesisofα-conotoxinGIDanaloguesasselectiveα4β2nicotinicacetylcholinereceptorantagoNISTs

Theα4β2nicotinicacetylcholinereceptor(nAChR)isanimportanttargetforcurrentlyapprovedsmokingcessationtherapeutics.However,thedevelopmentofhighlyselectiveα4β2nAChRantagonistsremainsasignificantchallenge.α-ConotoxinGIDisanantagonistofα4β2nAChRs,thoughitissignificantlymorepotenttowardtheα3β2andα7subtypes.Withthegoalofobtainingfurtherinsightsintoα-conotoxinGID/nAChRinteractionsthatcouldleadtothedesignofGIDanalogueswithimprovedaffinityforα4β2nAChRs,webuiltahomologymodeloftheGID/α4β2complexusinganX-rayco-crystalstructureofanα-conotoxin/acetylcholinebindingprotein(AChBP)complex.SeveraladditionalinteractionsthatcouldpotentiallyenhancetheaffinityofGIDforα4β2nAChRswereobservedinourmodel,whichledtothedesignandsynthesisof22GIDanalogues.Sevenanaloguesdisplayedinhibitoryactivitytowardα4β2nAChRsthatwascomparabletoGID.Significantly,bothGID[A10S]andGID[V13I]demonstratedmoderatelyimprovedselectivitytowardα4β2overα3β2whencomparedwithGID,whileGID[V18N]exhibitednomeasurableinhibitoryactivityfortheα3β2subtype,yetretainedinhibitoryactivityforα4β2.Inthisregard,GID[V18N]isthemostα4β2nAChRselectiveα-conotoxinanalogueidentifiedtodate.©2013WileyPeriodicals,Inc.Biopolymers(PeptSci)102:78-87,2014.

BanerjeeJ., etal. (2014) Designandsynthesisofα-conotoxinGIDanaloguesasselectiveα4β2nicotinicacetylcholinereceptorantagonists. Biopolymers. PMID: 24122487

InhibitionofNeuronalNicotinicAcetylcholineReceptorSubtypesbyα-ConotoxinGIDandAnalogues

Alpha-Conotoxinsaresmalldisulfide-richpeptidesfromthevenomoftheConusspeciesthattargetthenicotinicacetylcholinereceptor(nAChR).Theyarevaluablepharmacologicaltoolsandalsohavepotentialtherapeuticapplicationsparticularlyforthetreatmentofchronicpain.alpha-ConotoxinGIDisisolatedfromthevenomofConusgeographusandhasanunusualN-terminaltailsequencethathasbeenshowntobeimportantforbindingtothealpha4beta2subtypeofthenAChR.Todate,onlyfourconotoxinsthatinhibitthealpha4beta2subtypehavebeencharacterized,buttheyareofconsiderableinterestasitisthemostabundantnAChRsubtypeinthemammalianbrainandhasbeenimplicatedinarangeofdiseases.Inthisstudy,analysisofalanine-scanandtruncationmutantsofGIDrevealsthataconservedprolineinalpha-conotoxinsisimportantforactivityatthealpha7,alpha3beta2,andalpha4beta2subtypes.Althoughtheprolineresiduewasthemostcriticalresidueforactivityatthealpha3beta2subtype,Asp(3),Arg(12),andAsn(14)arealsocriticalatthealpha7subtype.Interestingly,veryfewofthemutationstestedretainedactivityatthealpha4beta2subtypeindicatingatightlydefinedbindingsite.Thislackoftolerancetosequencevariationmayexplainthelackofselectiveligandsdiscoveredforthealpha4beta2subtypetodate.Overall,ourfindingscontributetotheunderstandingofthestructure-activityrelationshipsofalpha-conotoxinsandmaybebeneficialfortheongoingattemptstoexploitmodulatorsoftheneuronalnAChRsastherapeuticagents.

MillardE., etal. (2009) InhibitionofNeuronalNicotinic AcetylcholineReceptorSubtypesby α-ConotoxinGIDandAnalogues.JBC. PMID: 19098004

Isolation,Structure,andActivityofGID,aNovel4/7-ConotoxinwithanExtendedN-terminalSequence

Usingassay-directedfractionationofConusgeographuscrudevenom,weisolatedalpha-conotoxinGID,whichactsselectivelyatneuronalnicotinicacetylcholinereceptors(nAChRs).Unlikeotherneuronallyselectivealpha-conotoxins,alpha-GIDhasafouraminoacidN-terminaltail,gamma-carboxyglutamate(Gla),andhydroxyproline(O)residues,andlacksanamidatedCterminus.GIDinhibitsalpha7andalpha3beta2nAChRswithIC(50)valuesof5and3nm,respectivelyandisatleast1000-foldlesspotentatthealpha1beta1gammadelta,alpha3beta4,andalpha4beta4combinations.GIDalsopotentlyinhibitsthealpha4beta2subtype(IC(50)of150nm).DeletionoftheN-terminalsequence(GIDDelta1-4)significantlydecreasedactivityatthealpha4beta2nAChRbuthardlyaffectedpotencyatalpha3beta2andalpha7nAChRs,despiteenhancingtheoff-ratesatthesereceptors.Incontrast,Arg(12)contributedtoalpha4beta2andalpha7activitybutnottoalpha3beta2activity.Thethree-dimensionalstructureofGIDiswelldefinedoverresidues4-19withasimilarmotiftootheralpha-conotoxins.However,despiteitsinfluenceonactivity,thetailappearstobedisorderedinsolution.ComparisonofGIDwithotheralpha4/7-conotoxinswhichpossessanNN(P/O)motifinloopII,revealedacorrelationbetweenincreasinglengthofthealiphaticside-chaininposition10(equivalentto13inGID)andgreateralpha7versusalpha3beta2selectivity.

NickeA., etal. (2003) Isolation,Structure,andActivityofGID,aNovel4/7-ConotoxinwithanExtendedN-terminalSequence. JBC. PMID: 12419800

品牌介绍
Smartox Biotechnology 是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。Smartox Biotechnology 于 2009 年由来自 Grenoble 神经科学研究所 (Grenoble Institute of Neuroscience) 的 Michel de waard 博士创立, Smartox Biotechnology 专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。 De Waard 博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽 (cell penetrating peptides, CPP) 。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。 2010 年, Smartox Biotechnolgy 被法国研究部 (Ministry of Research) 授予“新兴企业 OSEO 奖 (OSEO prize for emerging businesses) ”。